,i  #aafth ,,congress  #ast ,session    
,h4 ,r4 #cigd  ,,in ,,the ,,house ,,of  
,,representatives  ,july #be1 #bjai,mr4 
,ryan 7for himself and ,mr4 ,balderson7 
introduced the following bill2 which was
 referred to the ,committee on ,energy  
and ,commerce  ,a ,,bill  ,to require   
the use of prescription drug monitoring 
programs4  #a4 ,short title ,this ,act  
may be cited as the ,prescription ,drug 
,monitoring ,act of #bjai4  #b4         
,requiring the use of prescription drug 
monitoring programs  7a7 ,definitions   
,in this section3  7#a7 ,controlled     
substance ,the term controlled substance
 has the meaning given the term in      
section #ajb of the ,controlled         
,substances ,act 7#ba ,u4,s4,c4 #hjb74  
7#b7 ,covered ,state ,the term covered  
,state means a ,state that receives     
funding under the ,harold ,rogers       
,prescription ,drug ,monitoring ,program
 established under the ,departments of  
,commerce1 ,justice1 and ,state1 the    
,judiciary1 and ,related ,agencies      

,appropriations ,act1 #bjjb 7,public    
,law #ajg-gg2 #aae ,stat4 #gdh71 or     
under the controlled substance          
monitoring program under section #cii,o 
of the ,public ,health ,service ,act    
7#db ,u4,s4,c4 #bhj;g-#c74  7#c7        
,dispenser ,the term dispenser-- 7,a7   
means a person licensed or otherwise    
authorized by a ,state to deliver a     
prescription drug product to a patient  
or an agent of the patient2 and  7,b7   
does not include a person involved in   
oversight or payment for prescription   
drugs4  7#d7 ,,pdmp ,the term ,,pdmp    
means a prescription drug monitoring    
program4  7#e7 ,practitioner ,the term  
practitioner means a practitioner       
registered under section #cjc7;f7 of the
 ,controlled ,substances ,act 7#ba      
,u4,s4,c4 #hbc7;f77 to prescribe1       
administer1 or dispense controlled      
substances4  7#f7 ,state ,the term      
,state means each of the several ,states
 and the ,district of ,columbia4  7b7   
,requirements ,beginning #a year after  

the date of enactment of this ,act1 each
 covered ,state shall require--  7#a7   
each prescribing practitioner within the
 covered ,state or their designee1 who  
shall be licensed or registered         
healthcare professionals or other       
employees who report directly to the    
practitioner1 to consult the ,,pdmp of  
the covered ,state before initiating    
treatment with a prescription for a     
controlled substance listed in schedule 
,,ii1 ,,iii1 or ,,iv of section #bjb7;c7
 of the ,controlled ,substances ,act    
7#ba ,u4,s4,c4 #hab7;c771 and every #c  
months thereafter as long as the        
treatment continues2  7#b7 the ,,pdmp of
 the covered ,state to provide proactive
 notification to a practitioner when    
patterns indicative of controlled       
substance misuse1 including opioid      
misuse1 are detected2  7#c7 each        
dispenser within the covered ,state to  
report each prescription for a          
controlled substance dispensed by the   
dispenser to the ,,pdmp not later than  

#bd hours after the controlled substance
 is dispensed to the patient2  7#d7 that
 the ,,pdmp make available a quarterly  
de-identified data set and an annual    
report for public and private use1      
including use by healthcare providers1  
health plans and health benefits        
administrators1 ,state agencies1 and    
researchers1 which shall1 at a minimum1 
meet requirements established by the    
,attorney ,general1 in coordination with
 the ,secretary of ,health and ,human   
,services2  7#e7 each ,state agency that
 administers the ,,pdmp to-- 7,a7       
proactively analyze data available      
through the ,,pdmp2 and  7,b7 provide   
reports to law enforcement agencies and 
prescriber licensing boards describing  
any prescribing practitioner that       
repeatedly fall outside of expected     
norms or standard practices for the     
prescribing practitioner's field2 and   
7#f7 that the data contained in the     
,,pdmp of the covered ,state be made    
available to other ,states4  7c7        

,noncompliance ,if a covered ,state     
fails to comply with subsection 7a71 the
 ,attorney ,general or the ,secretary of
 ,health and ,human ,services may       
withhold grant funds from being awarded 
to the covered ,state under the ,harold 
,rogers ,prescription ,drug ,monitoring 
,program established under the          
,departments of ,commerce1 ,justice1 and
 ,state1 the ,judiciary1 and ,related   
,agencies ,appropriations ,act1 #bjjb   
7,public ,law #ajg-gg2 #aae ,stat4      
#gdh71 or under the controlled substance
 monitoring program under section #cii,o
 of the ,public ,health ,service ,act   
7#db ,u4,s4,c4 #bhj;g-#c74